Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors.

Kerckhove N, Boudieu L, Ourties G, Bourdier J, Daulhac L, Eschalier A, Mallet C.

Eur Neuropsychopharmacol. 2019 Dec;29(12):1419-1432. doi: 10.1016/j.euroneuro.2019.10.012. Epub 2019 Nov 22.

PMID:
31767519
2.

Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.

Kerckhove N, Busserolles J, Stanbury T, Pereira B, Plence V, Bonnetain F, Krakowski I, Eschalier A, Pezet D, Balayssac D.

BMJ Open. 2019 Jun 9;9(6):e027770. doi: 10.1136/bmjopen-2018-027770.

3.

New SPE-LC-MS/MS method for the simultaneous determination in urine of 22 metabolites of DEHP and alternative plasticizers from PVC medical devices.

Pinguet J, Kerckhove N, Eljezi T, Lambert C, Moreau E, Bernard L, Boeuf B, Decaudin B, Genay S, Masse M, Storme L, Sautou V, Richard D; ARMED Study Group.

Talanta. 2019 Jun 1;198:377-389. doi: 10.1016/j.talanta.2019.01.115. Epub 2019 Feb 6.

PMID:
30876575
4.

[Chemotherapy-induced peripheral neuropathy: Symptomatology and epidemiology].

Kerckhove N, Collin A, Condé S, Chaleteix C, Pezet D, Balayssac D, Guastella V.

Bull Cancer. 2018 Nov;105(11):1020-1032. doi: 10.1016/j.bulcan.2018.07.009. Epub 2018 Sep 20. Review. French.

PMID:
30244980
5.

Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin.

Poupon L, Lamoine S, Pereira V, Barriere DA, Lolignier S, Giraudet F, Aissouni Y, Meleine M, Prival L, Richard D, Kerckhove N, Authier N, Balayssac D, Eschalier A, Lazdunski M, Busserolles J.

Neuropharmacology. 2018 Sep 15;140:43-61. doi: 10.1016/j.neuropharm.2018.07.026. Epub 2018 Jul 26.

PMID:
30056126
6.

Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial.

Kerckhove N, Pereira B, Soriot-Thomas S, Alchaar H, Deleens R, Hieng VS, Serra E, Lanteri-Minet M, Arcagni P, Picard P, Lefebvre-Kuntz D, Maindet C, Mick G, Balp L, Lucas C, Creach C, Letellier M, Martinez V, Navez M, Delbrouck D, Kuhn E, Piquet E, Bozzolo E, Brosse C, Lietar B, Marcaillou F, Hamdani A, Leroux-Bromberg N, Perier Y, Vergne-Salle P, Gov C, Delage N, Gillet D, Romettino S, Richard D, Mallet C, Bernard L, Lambert C, Dubray C, Duale C, Eschalier A.

Eur J Pain. 2018 Aug;22(7):1321-1330. doi: 10.1002/ejp.1221. Epub 2018 Apr 18.

PMID:
29577519
8.

Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.

Kerckhove N, Collin A, Condé S, Chaleteix C, Pezet D, Balayssac D.

Front Pharmacol. 2017 Feb 24;8:86. doi: 10.3389/fphar.2017.00086. eCollection 2017. Review.

9.
10.

Clinical assessment of new antineuropathic strategies for chemotherapy-induced peripheral neuropathy: pain should not be the principal endpoint.

Kerckhove N, Pereira B, Pezet D, Balayssac D.

Pain. 2017 Jan;158(1):180-182. No abstract available.

PMID:
27984530
11.

Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.

Poupon L, Kerckhove N, Vein J, Lamoine S, Authier N, Busserolles J, Balayssac D.

Expert Opin Drug Saf. 2015 Aug;14(8):1269-82. doi: 10.1517/14740338.2015.1056777. Epub 2015 Jun 10. Review.

PMID:
26058312
12.

Ca(v)3.2 calcium channels: the key protagonist in the supraspinal effect of paracetamol.

Kerckhove N, Mallet C, François A, Boudes M, Chemin J, Voets T, Bourinet E, Alloui A, Eschalier A.

Pain. 2014 Apr;155(4):764-72. doi: 10.1016/j.pain.2014.01.015. Epub 2014 Jan 18.

PMID:
24447516
13.

State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.

Francois A, Kerckhove N, Meleine M, Alloui A, Barrere C, Gelot A, Uebele VN, Renger JJ, Eschalier A, Ardid D, Bourinet E.

Pain. 2013 Feb;154(2):283-93. doi: 10.1016/j.pain.2012.10.023. Epub 2012 Nov 5.

PMID:
23257507

Supplemental Content

Loading ...
Support Center